申请人:——
公开号:US20030135056A1
公开(公告)日:2003-07-17
A novel class of imidazo heterocyclic compounds, pharmaceutical compositions comprising them and use thereof in the treatment and/or prevention of diseases and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment and/or prevention of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial.
一种新型咪唑杂环化合物、包含它们的制药组合物以及在治疗和/或预防与组胺H3受体有关的疾病和障碍方面的应用。更具体地说,这些化合物对于治疗和/或预防与组胺H3受体相互作用有益的疾病和障碍是有用的。